Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: Product withdrawal
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 6 of 6 items.
Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access
AlertHealth professional risk communication | 2024-06-07
IDHIFA (enasidenib mesylate) – Market Withdrawal and Continued Access
AlertHealth professional risk communication | 2023-06-08
ISTODAX (romidepsin) – Restricted Access Program
AlertHealth professional risk communication | 2023-03-20
RUZURGI (amifampridine) - Authorization Status
AlertHealth professional risk communication | 2023-01-20
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
RecallHealth product recall | 2022-08-22
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20